The Jikei University School of Medicine · Graduate School of Medicine / Faculty of Medicine · 助教

Research keywordsmultiple myeloma・minimal residual disease・daratumumab・anti-CD38 monoclonal antibodies・lymphocyte-to-monocyte ratio・proteasome inhibitors・immunomodulatory drugs・cast nephropathy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
• 骨髄腫における微小残存病変の臨床的な意義:単施設後方視的研究(Clinical significance of minimal residual disease in myeloma; single center retrospective analysis)
• 初発多発性骨髄腫の骨髄腫腎に対してDVd療法を施行した3例(Daraturnumab, bortezomib, and dexamethasone in three multiple myeloma patients presenting cast nephropathy)
• プロテアソーム阻害剤を用いたポンペ病に対する新規シャペロン療法の開発

• Official profile